300791SZSE

Special Explanation on Fund Occupation by Controlling Shareholders, Actual Controllers, and Other Related Parties of Sinolife Health Technology Co., Ltd.

Sirio Pharma Co., Ltd.··3 pages

✨ AI Summary

This report details the fund occupation and other related party transactions for Sinolife Health Technology Co., Ltd. in 2025. It confirms that the company's management is responsible for the accuracy of the disclosed information. The auditors performed limited procedures, cross-referencing the disclosed data with audited financial statements, and found no material inconsistencies.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Deloitte. 德勤 德勤华永会计师事务所(特殊普通合伙) 上海市延安东路222号 外滩中心30楼 邮政编码: 200002

Special Explanation on Fund Occupation by Controlling Shareholders, Actual Controllers, and Other Related Parties of Sinolife Health Technology Co., Ltd.

To the Board of Directors of Sinolife Health Technology Co., Ltd.:

We have been engaged to audit the consolidated and parent company balance sheets of Sinolife Health Technology Co., Ltd. as of December 31, 2025, and the consolidated and parent company income statements, consolidated and parent company cash flow statements, consolidated and parent company statements of changes in owners' equity, and related financial statement notes (collectively, the "Financial Statements") for the year ended December 31, 2025. We issued our unqualified audit report dated April 23, 2026, with report number [blank].

In accordance with the requirements of the "Supervision Requirements for Listed Companies on Fund Transactions and External Guarantees" issued by the China Securities Regulatory Commission, the Ministry of Public Security, the State-owned Assets Supervision and Administration Commission of the State Council, and the China Banking and Insurance Regulatory Commission, the Company has prepared the attached summary table of non-operating fund occupation and other related party fund transactions for 2025 (the "Summary Table").

The accurate preparation and external disclosure of the Summary Table and ensuring its truthfulness, legality, and completeness are the responsibility of the Company's management. We have cross-checked the information in the Summary Table with the accounting information reviewed and the audited financial statements of the Company for the year 2025, and we have found no inconsistencies in all material aspects. Except for the audit procedures related to related party transactions performed as part of our audit of the Company's 2025 financial statements in accordance with Chinese Certified Public Accountants' auditing standards, we have not performed any additional audit procedures on the information contained in the Summary Table.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.